Corebridge Financial’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,047	Closed	-$66.5K	–	2219
2025 Q1	$66.5K	Sell	5,047 -75	-1%	-$988	﹤0.01%	2636
2024 Q4	$91.7K	Buy	5,122 +1,258	+33%	+$22.5K	﹤0.01%	2590
2024 Q3	$62.3K	Sell	3,864 -24	-0.6%	-$387	﹤0.01%	2808
2024 Q2	$105K	Buy	+3,888	New	+$105K	﹤0.01%	2576